Tumor Marker Testing Market 2017-2022: US, Europe, Japan--Supplier Country Shares, Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Manufacturers, Country Volume and Sales Forecasts

January 2018 | 104 pages | ID: TC912ACEA16EN
Venture Planning Group

Abstracts

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 104 pages and 3 tables

Contents

1. WORLDWIDE BUSINESS ENVIRONMENT

2. WORLDWIDE MARKET STRUCTURE

3. WORLDWIDE MARKET SIZE AND GROWTH

4. COMPETITIVE ASSESSMENTS:

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Gentics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetic
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher
Veridex
Wako Pure Chemicals
Wallac/PE
Zila/Alere

List Of Tables

LIST OF TABLES

Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country
Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country
Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country